Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the door open for off-label use
Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the [...]
Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the [...]
Samsung Biologics outlines mRNA ambitions as “Super Plant” speeds toward [...]
Gilead pulls 2 cancer accelerated approvals as changing lymphoma landscape [...]
On second thought, Oncopeptides decides not to give up on [...]
Pfizer takes a surprising hit to its rare disease plan [...]
Poland’s largest pharma scouts for joint bidder in potential $4B [...]
Fierce JPM Week: Bristol Myers’ next-gen autoimmune med not just another [...]
It’s a matter of national security: Sanofi doesn’t want new [...]
GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand [...]
You say Trintellix, I say Brintellix: Why a drug name [...]